| review article | Q7318358 |
| scholarly article | Q13442814 |
| P50 | author | Daniel E Rusyniak | Q42869909 |
| P2093 | author name string | Jon E Sprague | |
| Edward M Mills | |||
| P2860 | cites work | BMCP1, a novel mitochondrial carrier with high expression in the central nervous system of humans and rodents, and respiration uncoupling activity in recombinant yeast | Q22008535 |
| Uncoupling protein-3: a new member of the mitochondrial carrier family with tissue-specific expression | Q24309291 | ||
| UCP3: an uncoupling protein homologue expressed preferentially and abundantly in skeletal muscle and brown adipose tissue | Q24312228 | ||
| Uncoupling protein-2: a novel gene linked to obesity and hyperinsulinemia | Q24324798 | ||
| Disruption of the uncoupling protein-2 gene in mice reveals a role in immunity and reactive oxygen species production | Q28139177 | ||
| Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin | Q28143430 | ||
| Cloning and characterization of the 5' flanking region of the human uncoupling protein 3 (UCP3) gene | Q28144070 | ||
| Five fatal cases of serotonin syndrome after moclobemide-citalopram or moclobemide-clomipramine overdoses | Q28236980 | ||
| Uncoupling protein-3 is a mediator of thermogenesis regulated by thyroid hormone, beta3-adrenergic agonists, and leptin | Q28249563 | ||
| Rhabdomyolysis and shock after intravenous amphetamine administration | Q28331084 | ||
| Thyroid hormone--sympathetic interaction and adaptive thermogenesis are thyroid hormone receptor isoform--specific | Q28343412 | ||
| Hyperpyrexia and rhabdomyolysis after MDMA ("ecstasy") abuse | Q45261240 | ||
| Distribution of the uncoupling protein 2 mRNA in the mouse brain | Q47702823 | ||
| Selective detection of UCP 3 expression in skeletal muscle: effect of thyroid status and temperature acclimation | Q47789118 | ||
| Tissue-dependent upregulation of rat uncoupling protein-2 expression in response to fasting or cold | Q48047137 | ||
| The distribution of 3,4-methylenedioxymethamphetamine "Ecstasy"-induced c-fos expression in rat brain | Q48149811 | ||
| Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine | Q48263524 | ||
| Pharmacodynamic effects of serotonin (5-HT) receptor ligands in pigs: stimulation of 5-HT2 receptors induces malignant hyperthermia | Q48963025 | ||
| Studies with amphetamine in hyper- and hypothyroid rats | Q51205071 | ||
| Norepinephrine does not potentiate porcine malignant hyperthermia. | Q51575126 | ||
| Lack of prophylactic or therapeutic efficacy of 5-HT2A receptor antagonists in halothane-induced porcine malignant hyperthermia. | Q51624085 | ||
| Central and peripheral mechanisms in the stimulation of adrenocortical secretion by the 5-hydroxytryptamine2 agonist, (+-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane. | Q51626406 | ||
| Drug-induced hyperthermia. | Q51655303 | ||
| Severe hyperthermia secondary to intravenous drug abuse. | Q51841585 | ||
| Effects of psychoactive drugs on plasma catecholamines during stress in rats. | Q51846499 | ||
| Ecstasy, serotonin syndrome and the treatment of hyperpyrexia. | Q51999861 | ||
| Mitochondrial uncoupling proteins and phylogenesis--UCP4 as the ancestral uncoupling protein. | Q52587939 | ||
| PENTACHLOROPHENOL POISONING: REPORT OF TWO CASES | Q52637895 | ||
| Porcine malignant hyperthermia. VI: the effects of bilateral adrenalectomy and pretreatment with bretylium on the halothane-induced response | Q52706545 | ||
| Release of respiratory control by uncouplers: The question of stoichiometry | Q52974717 | ||
| Autoradiographic delineation of skeletal muscle alpha 1-adrenergic receptor distribution. | Q54313372 | ||
| Dinitrophenol Poisoning | Q56031570 | ||
| Exaltation of Toxicity of Sympathomimetic Amines by Thyroxine | Q58956813 | ||
| Effects of thyroid hormone on norepinephrine signaling in brown adipose tissue. I. Beta 1- and beta 2-adrenergic receptors and cyclic adenosine 3',5'-monophosphate generation | Q59680321 | ||
| Another death from Ecstacy | Q67880657 | ||
| Effects of 3,4-methylenedioxymethamphetamine on autonomic thermoregulatory responses of the rat | Q68305346 | ||
| Ecstasy, 3–4 Methylenedioxymethamphetamine (MDMA), a Fatality Associated with Coagulopathy and Hyperthermia | Q68306116 | ||
| The proton leak across the mitochondrial inner membrane | Q68902256 | ||
| 'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA | Q69894571 | ||
| Multiple severe complications from recreational ingestion of MDMA ('Ecstasy') | Q69903240 | ||
| The pharmacology of the acute hyperthermic response that follows administration of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') to rats | Q28344876 | ||
| Vascular actions of MDMA involve alpha1 and alpha2-adrenoceptors in the anaesthetized rat | Q28365866 | ||
| 'Ecstasy' ingestion: a case report of severe complications | Q28369502 | ||
| Lack of obesity and normal response to fasting and thyroid hormone in mice lacking uncoupling protein-3 | Q28506464 | ||
| Mice lacking mitochondrial uncoupling protein are cold-sensitive but not obese | Q28510931 | ||
| On the mechanism of fatty acid-induced proton transport by mitochondrial uncoupling protein | Q28646366 | ||
| Superoxide activates mitochondrial uncoupling protein 2 from the matrix side. Studies using targeted antioxidants | Q28771379 | ||
| Topology of superoxide production from different sites in the mitochondrial electron transport chain | Q29619855 | ||
| MDMA (ecstasy) and the rave: a review | Q30471049 | ||
| Uncoupling protein-2 prevents neuronal death and diminishes brain dysfunction after stroke and brain trauma | Q31149457 | ||
| Serotonin syndrome. Presentation of 2 cases and review of the literature | Q33913660 | ||
| Mitochondrial targets of drug toxicity | Q33932157 | ||
| Uncoupling proteins 2 and 3: potential regulators of mitochondrial energy metabolism. | Q33951526 | ||
| Mitochondrial proton leak and the uncoupling protein 1 homologues. | Q34175428 | ||
| 5-hydroxytryptamine(2A) receptors regulate sympathetic nerves constricting the cutaneous vascular bed in rabbits and rats | Q34185697 | ||
| Skin Blood Flow in Adult Human Thermoregulation: How It Works, When It Does Not, and Why | Q34196550 | ||
| Dinitrophenol and bioenergetics: an historical perspective | Q34214669 | ||
| The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy"). | Q34215236 | ||
| Dinitrophenol poisoning: a diagnosis to consider in undiagnosed fever | Q34277627 | ||
| Accidental ingestion of Ecstasy by a toddler: unusual cause for convulsion in a febrile child | Q34292207 | ||
| Sympathoadrenal hyperactivity and the etiology of neuroleptic malignant syndrome | Q34492762 | ||
| Pentachlorophenol Poisoning | Q34542823 | ||
| Stereochemical effects of 3,4-methylenedioxymethamphetamine (MDMA) and related amphetamine derivatives on inhibition of uptake of [3H]monoamines into synaptosomes from different regions of rat brain | Q34559625 | ||
| Neuroleptic malignant syndrome: a pathogenetic role for dopamine receptor blockade? | Q34707116 | ||
| The health effects of ecstasy: a literature review | Q34790879 | ||
| Thyroid hormone and uncoupling proteins. | Q35130103 | ||
| Beta-Adrenergic receptors, diet-induced thermogenesis, and obesity | Q35146380 | ||
| Effects of amphetamines on mitochondrial function: role of free radicals and oxidative stress | Q35153738 | ||
| A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. | Q35561876 | ||
| Acute renal failure after ecstasy | Q35822418 | ||
| The hyperthermic and neurotoxic effects of ‘Ecstasy’ (MDMA) and 3,4 methylenedioxyamphetamine (MDA) in the Dark Agouti (DA) rat, a model of the CYP2D6 poor metabolizer phenotype | Q35872606 | ||
| Ligand binding properties of putative beta 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes | Q36329762 | ||
| Clozapine. A novel antipsychotic agent | Q36485618 | ||
| Expression of uncoupling protein in skeletal muscle and white fat of obese mice treated with thermogenic beta 3-adrenergic agonist | Q37356667 | ||
| Pituitary-adrenal axis responses to acute amphetamine in the rat | Q70465842 | ||
| Deaths attributed to "ecstasy" overdose | Q71133185 | ||
| Further evidence for a physiological role for hypothalamic dopamine in thermoregulation in the rat | Q71215803 | ||
| Isolation of the uncoupling protein from brown adipose tissue mitochondria | Q71238619 | ||
| A fatal trip with ecstasy: a case of 3,4-methylenedioxymethamphetamine/3,4- methylenedioxyamphetamine toxicity | Q71262710 | ||
| Co-administration of MDMA with drugs that protect against MDMA neurotoxicity produces different effects on body temperature in the rat | Q71418782 | ||
| Amphetamine-induced hyperthyroxinemia | Q71540511 | ||
| Constant-pressure perfusion of rat hindlimb shows alpha- and beta-adrenergic stimulation of oxygen consumption | Q71569195 | ||
| Contribution of mitochondrial proton leak to skeletal muscle respiration and to standard metabolic rate | Q71738047 | ||
| Pentachlorophenol poisoning | Q71832790 | ||
| Fatty acid binding site of the mitochondrial uncoupling protein. Demonstration of its existence by EPR spectroscopy of 5-DOXYL-stearic acid | Q72375094 | ||
| Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case report | Q72485521 | ||
| Malignant hyperthermia | Q72744300 | ||
| Isolation of the GDP binding protein from brown adipose tissue mitochondria of several animals and amino acid composition study in rat | Q72939123 | ||
| Dantrolene and "ecstasy" | Q73129656 | ||
| The tissue distribution of the human beta3-adrenoceptor studied using a monoclonal antibody: direct evidence of the beta3-adrenoceptor in human adipose tissue, atrium and skeletal muscle | Q73170902 | ||
| Abnormal monoamine metabolism in cerebrospinal fluid in a case of serotonin syndrome | Q73398433 | ||
| Risperidone counteracts lethality in an animal model of the serotonin syndrome | Q73926619 | ||
| alpha1-Adrenergic stimulation potentiates the thermogenic action of beta3-adrenoreceptor-generated cAMP in brown fat cells | Q73959904 | ||
| beta 3-Adrenergic agonist induces a functionally active uncoupling protein in fat and slow-twitch muscle fibers | Q74408494 | ||
| Expression of uncoupling protein-3 and mitochondrial activity in the transition from hypothyroid to hyperthyroid state in rat skeletal muscle | Q74528007 | ||
| Death by "ecstasy": the serotonin syndrome? | Q77298855 | ||
| Sympatho-adrenal involvement in methamphetamine-induced hyperthermia through skeletal muscle hypermetabolism | Q77768271 | ||
| Thyroid hormone and other regulators of uncoupling proteins | Q78148450 | ||
| Immunohistochemical identification of the beta(3)-adrenoceptor in intact human adipocytes and ventricular myocardium: effect of obesity and treatment with ephedrine and caffeine | Q78536813 | ||
| Plasma levels of norepinephrine and epinephrine during malignant hyperthermia in susceptible pigs | Q93672806 | ||
| Facilitating prompt diagnosis and treatment of the neuroleptic malignant syndrome | Q37434651 | ||
| Obesity induces expression of uncoupling protein-2 in hepatocytes and promotes liver ATP depletion | Q38327948 | ||
| Brown adipose tissue thermogenesis and obesity | Q38752138 | ||
| Porcine malignant hyperthermia. III: Adrenergic blockade | Q39111817 | ||
| Pathology of deaths associated with "ecstasy" and "eve" misuse | Q39582464 | ||
| Thermogenic Mechanisms and their Control | Q39723358 | ||
| Pentachlorophenol intoxication: report of a fatal case, with comments on the clinical course and pathologic anatomy | Q39859988 | ||
| Brown fat and thermogenesis | Q39979072 | ||
| Regulation of metabolic processes in brown adipose tissue in relation to nonshivering thermogenesis | Q39993733 | ||
| Superoxide-mediated activation of uncoupling protein 2 causes pancreatic beta cell dysfunction. | Q40348831 | ||
| Methylenedioxyamphetamine. Clinical description of overdose, death, and review of pharmacology | Q40355152 | ||
| Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy"). | Q40483217 | ||
| The role of mitochondrial uncoupling in 3,4-methylenedioxymethamphetamine-mediated skeletal muscle hyperthermia and rhabdomyolysis | Q40517394 | ||
| Attenuation of 3,4-methylenedioxymethamphetamine (MDMA, Ecstasy)-induced rhabdomyolysis with alpha1- plus beta3-adrenoreceptor antagonists. | Q40533420 | ||
| The effects of ecstasy (MDMA) on rat liver bioenergetics | Q40539746 | ||
| Pharmacology: uncoupling the agony from ecstasy | Q40544943 | ||
| Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats. | Q40554405 | ||
| Hypothalamic-pituitary-thyroid axis and sympathetic nervous system involvement in hyperthermia induced by 3,4-methylenedioxymethamphetamine (Ecstasy). | Q40563105 | ||
| Diazepam and chlormethiazole attenuate the development of hyperthermia in an animal model of the serotonin syndrome | Q40564220 | ||
| Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits. | Q40594777 | ||
| Exertional heat stroke induced by amphetamine analogues. Does dantrolene have a place? | Q40619858 | ||
| Hyperthermia in psychostimulant overdose | Q40660374 | ||
| MDMA induced hyperthermia: report of a fatality and review of current therapy | Q40664329 | ||
| The causes and functions of mitochondrial proton leak | Q40696613 | ||
| CNS regulation of thermogenesis. | Q40707158 | ||
| Beta 3-adrenergic agonist up-regulates uncoupling proteins 2 and 3 in skeletal muscle of the mouse | Q40812155 | ||
| Amphetamine intoxication with coagulopathy, hyperthermia, and reversible renal failure. A syndrome resembling heatstroke | Q40931959 | ||
| Ecstasy intoxication: an overlap between serotonin syndrome and neuroleptic malignant syndrome | Q41088338 | ||
| Toxicity and deaths from 3,4-methylenedioxymethamphetamine ("ecstasy") | Q41110153 | ||
| Effect of 3,4-Methylenedioxymethamphetamine on 3,4-Dihydroxyphenylalanine Accumulation in the Striatum and Nucleus Accumbens | Q41136324 | ||
| Serotonin syndrome. A clinical update | Q41612469 | ||
| Ecstasy-induced rhabdomyolysis and its role in the development of acute renal failure | Q41631578 | ||
| Cerebrospinal fluid levels of monoamine metabolites and gamma-aminobutyric acid in neuroleptic malignant syndrome | Q42274346 | ||
| Ecstasy and the dance of death | Q42999285 | ||
| Intravenous cocaine increases plasma epinephrine and norepinephrine in humans | Q43590212 | ||
| Overexpression of uncoupling protein 2 inhibits glucose-stimulated insulin secretion from rat islets. | Q43616980 | ||
| Increase of serotonin in plasma during onset of halothane-induced malignant hyperthermia in pigs | Q43810465 | ||
| Presence of alpha-1 adrenoreceptors on thermosensitive neurons in the medial preoptico-anterior hypothalamic area in rats. | Q43977406 | ||
| Regulation of cellular oncosis by uncoupling protein 2. | Q43993754 | ||
| Plasma concentrations of 5-HT, 5-HIAA, norepinephrine, epinephrine and dopamine in ecstasy users. | Q44038887 | ||
| Excess recovery heat production by isolated muscles from mice overexpressing uncoupling protein-3. | Q44049315 | ||
| Selective 5-hydroxytryptamine2 receptor antagonists protect against the neurotoxicity of methylenedioxymethamphetamine in rats. | Q44143963 | ||
| Mitochondrial respiration in muscle and liver from cold-acclimated hypothyroid rats | Q44495373 | ||
| Effects of a 5HT(2) receptor agonist on anaesthetized pigs susceptible to malignant hyperthermia | Q44524167 | ||
| Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-targeted spin trap derived from alpha-phenyl-N-tert-butylnitrone. | Q44583900 | ||
| Abnormal CSF Monoamine Metabolism in Serotonin Syndrome | Q44603314 | ||
| Induction of Malignant Hyperthermia in Susceptible Swine by 3,4-Methylenedioxymethamphetamine (“Ecstasy”) | Q44630646 | ||
| The role of sympathetic activity in initiating malignant hyperthermia | Q44686206 | ||
| Centrally mediated release by cocaine of endogenous epinephrine and norepinephrine from the sympathoadrenal medullary system of unanesthetized rats | Q44776431 | ||
| UCP3 and thyroid hormone involvement in methamphetamine-induced hyperthermia | Q45042241 | ||
| P433 | issue | 12 | |
| P921 | main subject | thermogenesis | Q965695 |
| nervous system | Q9404 | ||
| P304 | page(s) | 787-799 | |
| P577 | publication date | 2004-11-10 | |
| P1433 | published in | Journal of Molecular Medicine | Q6295593 |
| P1476 | title | The role of the sympathetic nervous system and uncoupling proteins in the thermogenesis induced by 3,4-methylenedioxymethamphetamine | |
| P478 | volume | 82 |
| Q35851128 | A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) |
| Q44876434 | A novel amino acid and metabolomics signature in mice overexpressing muscle uncoupling protein 3. |
| Q36410788 | A review of acute effects of 3,4-methylenedioxymethamphetamine in healthy volunteers |
| Q35792449 | Acetaminophen and diphenhydramine premedication for allergic and febrile nonhemolytic transfusion reactions: good prophylaxis or bad practice? |
| Q22252248 | Attention-Deficit Hyperactivity Disorder and the Athlete: New Advances and Understanding |
| Q34279284 | Caffeine provokes adverse interactions with 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') and related psychostimulants: mechanisms and mediators |
| Q36252777 | Carvedilol inhibits the cardiostimulant and thermogenic effects of MDMA in humans. |
| Q33554672 | Catechol-o-methyltransferase and 3,4-({+/-})-methylenedioxymethamphetamine toxicity |
| Q91866944 | Conserving wildlife in a changing world: Understanding capture myopathy-a malignant outcome of stress during capture and translocation |
| Q81153875 | Differential behavioral syndrome evoked in the rats after multiple doses of SSRI fluoxetine with selective MAO inhibitors rasagiline or selegiline |
| Q40449090 | Does hyperthyroidism increase risk of death due to the ingestion of ecstasy? |
| Q48152837 | Drugs and bugs: turning on the heat through UCP1 and UCP3. |
| Q37226598 | Effects of MDMA on body temperature in humans |
| Q48250458 | Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination |
| Q50549548 | Human pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) after repeated doses taken 2 h apart. |
| Q35001625 | Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys |
| Q35186657 | Identification of a possible role for atrial natriuretic peptide in MDMA-induced hyperthermia |
| Q36149138 | Impact of ambient temperature on hyperthermia induced by (+/-)3,4-methylenedioxymethamphetamine in rhesus macaques |
| Q92574029 | Individuals with Hyperthyroidism are More Susceptible to having a Serious Serotonin Syndrome Following MDMA (Ecstasy) Administration in Rats |
| Q40448851 | Influence of dietary fats on Ecstasy-induced hyperthermia |
| Q35085894 | Influences of activity wheel access on the body temperature response to MDMA and methamphetamine |
| Q64107544 | Molecular Toxicological Mechanisms of Synthetic Cathinones on C2C12 Myoblasts |
| Q96303464 | P2X7 Receptor in the Management of Energy Homeostasis: Implications for Obesity, Dyslipidemia, and Insulin Resistance |
| Q37339908 | Pharmacodynamic characterization of insulin on MDMA-induced thermogenesis |
| Q30415540 | Prenatal antidepressant exposure: clinical and preclinical findings |
| Q45718517 | Protective effects of N-acetylcysteine on 3, 4-methylenedioxymethamphetamine-induced neurotoxicity in male Sprague-Dawley rats. |
| Q36003842 | Serotonin neurotoxins--past and present |
| Q33652473 | Serotonin reuptake transporter deficiency modulates the acute thermoregulatory and locomotor activity response to 3,4-(±)-methylenedioxymethamphetamine, and attenuates depletions in serotonin levels in SERT-KO rats |
| Q42112531 | Studies on the effect of MDMA ('ecstasy') on the body temperature of rats housed at different ambient room temperatures |
| Q38190773 | Synthetic cathinones ("bath salts"). |
| Q38819582 | The complementary and divergent roles of uncoupling proteins 1 and 3 in thermoregulation. |
| Q34112933 | The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives |
| Q22252794 | Toxicity of amphetamines: an update |
Search more.